Diabetes, Vol 35, Issue 5 530-545, Copyright © 1986 by American Diabetes Association

ARTICLES

The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT Research Group

The Diabetes Control and Complications Trial (DCCT) is a randomized, controlled clinical trial designed to assess the relationship between glycemic control and the development, progression, or amelioration of early vascular complications in persons with insulin-dependent diabetes mellitus (IDDM). The DCCT consists of two parallel studies: a primary prevention study and a secondary intervention study. The principal outcome in the primary prevention study is the initial appearance and subsequent progression of background retinopathy. In the secondary intervention study, the principal outcome is the progression or amelioration of preexistent minimal retinopathy. Subjects are randomly assigned to receive either experimental or standard therapy. Experimental therapy involves the use of an intensive insulin regimen designed to maintain near-normal glycemic levels in the absence of severe hypoglycemia. Standard treatment is designed to maintain near-normal glycemic levels in the absence of severe hypoglycemia. Standard treatment is designed to maintain subjects free of clinical symptoms related to hyper- or hypoglycemia while receiving up to two insulin injections daily. Two hundred seventy-eight volunteers have been enrolled in 21 centers in the United States and Canada in a preliminary study to assess the feasibility of conducting a full-scale, long-term clinical trial. Based on an external review of the feasibility study results, the DCCT will be expanded to include over 1400 subjects treated for a period of up to 10 yr. This article describes the DCCT and the considerations that led to the choice of specific design features for the feasibility phase.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. F.A. Grant, H.-Q. Qu, J. P. Bradfield, L. Marchand, C. E. Kim, J. T. Glessner, R. Grabs, S. P. Taback, E. C. Frackelton, A. W. Eckert, et al. Follow-Up Analysis of Genome-Wide Association Data Identifies Novel Loci for Type 1 Diabetes Diabetes, January 1, 2009; 58(1): 290 - 295. [Abstract] [Full Text] [PDF]

				L. N. Pani, L. Korenda, J. B. Meigs, C. Driver, S. Chamany, C. S. Fox, L. Sullivan, R. B. D'Agostino, and D. M. Nathan Effect of Aging on A1C Levels in Individuals Without Diabetes: Evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001-2004 Diabetes Care, October 1, 2008; 31(10): 1991 - 1996. [Abstract] [Full Text] [PDF]

				E S Kilpatrick Haemoglobin A1c in the diagnosis and monitoring of diabetes mellitus J. Clin. Pathol., September 1, 2008; 61(9): 977 - 982. [Abstract] [Full Text] [PDF]

				H. Al-Kateb, A. P. Boright, L. Mirea, X. Xie, R. Sutradhar, A. Mowjoodi, B. Bharaj, M. Liu, J. M. Bucksa, V. L. Arends, et al. Multiple Superoxide Dismutase 1/Splicing Factor Serine Alanine 15 Variants Are Associated With the Development and Progression of Diabetic Nephropathy: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Genetics Study Diabetes, January 1, 2008; 57(1): 218 - 228. [Abstract] [Full Text] [PDF]

				A. D. Paterson, B. N. Rutledge, P. A. Cleary, J. M. Lachin, R. S. Crow, and for the Diabetes Control and Complications Trial/E The Effect of Intensive Diabetes Treatment on Resting Heart Rate in Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Diabetes Care, August 1, 2007; 30(8): 2107 - 2112. [Abstract] [Full Text] [PDF]

				S. D. Sibley, I. H. de Boer, M. W. Steffes, J. D. Brunzell, and the Diabetes Control and Complications Trial/Epide Intra-Abdominal Fat and Elevated Urine Albumin Excretion in Men With Type 1 Diabetes Diabetes Care, July 1, 2007; 30(7): 1898 - 1900. [Full Text] [PDF]

				The Mount Hood 4 Modeling Group Computer Modeling of Diabetes and Its Complications: A report on the Fourth Mount Hood Challenge Meeting Diabetes Care, June 1, 2007; 30(6): 1638 - 1646. [Abstract] [Full Text] [PDF]

				R. G. Hiss, B. A. Armbruster, M. L. Gillard, and L. A. McClure Nurse Care Manager Collaboration With Community-Based Physicians Providing Diabetes Care: A Randomized Controlled Trial The Diabetes Educator, May 1, 2007; 33(3): 493 - 502. [Abstract] [Full Text] [PDF]

				E. S. Kilpatrick, A. S. Rigby, and S. L. Atkin Variability in the Relationship between Mean Plasma Glucose and HbA1c: Implications for the Assessment of Glycemic Control Clin. Chem., May 1, 2007; 53(5): 897 - 901. [Abstract] [Full Text] [PDF]

				P. J. Dyck, J. L. Davies, V. M. Clark, W. J. Litchy, P. J. B. Dyck, C. J. Klein, R. A. Rizza, J. M. Pach, R. Klein, T. S. Larson, et al. Modeling Chronic Glycemic Exposure Variables as Correlates and Predictors of Microvascular Complications of Diabetes Diabetes Care, October 1, 2006; 29(10): 2282 - 2288. [Abstract] [Full Text] [PDF]

				The Diabetes Control and Complications Trial/Epide Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes N. Engl. J. Med., December 22, 2005; 353(25): 2643 - 2653. [Abstract] [Full Text] [PDF]

				A. P. Boright, A. D. Paterson, L. Mirea, S. B. Bull, A. Mowjoodi, S. W. Scherer, B. Zinman, and and the DCCT/EDIC Research Group Genetic Variation at the ACE Gene Is Associated With Persistent Microalbuminuria and Severe Nephropathy in Type 1 Diabetes: The DCCT/EDIC Genetics Study Diabetes, April 1, 2005; 54(4): 1238 - 1244. [Abstract] [Full Text] [PDF]

				M. Steffes, P. Cleary, D. Goldstein, R. Little, H.-M. Wiedmeyer, C. Rohlfing, J. England, J. Bucksa, M. Nowicki, and the DCCT/EDIC Research Group Hemoglobin A1c Measurements over Nearly Two Decades: Sustaining Comparable Values throughout the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications Study Clin. Chem., April 1, 2005; 51(4): 753 - 758. [Abstract] [Full Text] [PDF]

				B. Miljanovic, R. J. Glynn, D. M. Nathan, J. E. Manson, and D. A. Schaumberg A Prospective Study of Serum Lipids and Risk of Diabetic Macular Edema in Type 1 Diabetes Diabetes, November 1, 2004; 53(11): 2883 - 2892. [Abstract] [Full Text] [PDF]

				A. E. Kitabchi Ketosis-Prone Diabetes--A New Subgroup of Patients with Atypical Type 1 and Type 2 Diabetes? J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5087 - 5089. [Full Text] [PDF]

				J. Q. Purnell, R. K. Dev, M. W. Steffes, P. A. Cleary, J. P. Palmer, I. B. Hirsch, J. E. Hokanson, and J. D. Brunzell Relationship of Family History of Type 2 Diabetes, Hypoglycemia, and Autoantibodies to Weight Gain and Lipids With Intensive and Conventional Therapy in the Diabetes Control and Complications Trial Diabetes, October 1, 2003; 52(10): 2623 - 2629. [Abstract] [Full Text] [PDF]

				M. C. Cheung, S. D. Sibley, J. P. Palmer, J. F. Oram, and J. D. Brunzell Lipoprotein lipase and hepatic lipase: their relationship with HDL subspecies Lp(A-I) and Lp(A-I,A-II) J. Lipid Res., August 1, 2003; 44(8): 1552 - 1558. [Abstract] [Full Text] [PDF]

				S. D. Sibley, J. P. Palmer, I. B. Hirsch, and J. D. Brunzell Visceral Obesity, Hepatic Lipase Activity, and Dyslipidemia in Type 1 Diabetes J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3379 - 3384. [Abstract] [Full Text] [PDF]

				B. J. Anderson Who Benefits From Intensive Therapy in Type 1 Diabetes?: A fresh perspective, more questions, and hope Diabetes Care, July 1, 2003; 26(7): 2204 - 2206. [Full Text] [PDF]

				R. L. Klein, S. J. Hunter, A. J. Jenkins, D. Zheng, A. J. Semler, J. Clore, W. T. Garvey, and The DCCT/EDIC Study Group Fibrinogen Is a Marker for Nephropathy and Peripheral Vascular Disease in Type 1 Diabetes: Studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort Diabetes Care, May 1, 2003; 26(5): 1439 - 1448. [Abstract] [Full Text] [PDF]

				G. E. Umpierrez, K. A. Latif, M. B. Murphy, H. C. Lambeth, F. Stentz, A. Bush, and A. E. Kitabchi Thyroid Dysfunction in Patients With Type 1 Diabetes: A longitudinal study Diabetes Care, April 1, 2003; 26(4): 1181 - 1185. [Abstract] [Full Text] [PDF]

				A. S. Ametov, A. Barinov, P. J. Dyck, R. Hermann, N. Kozlova, W. J. Litchy, P. A. Low, D. Nehrdich, M. Novosadova, P. C. O'Brien, et al. The Sensory Symptoms of Diabetic Polyneuropathy Are Improved With {alpha}-Lipoic Acid: The SYDNEY Trial Diabetes Care, March 1, 2003; 26(3): 770 - 776. [Abstract] [Full Text] [PDF]

				M. W. Steffes, S. Sibley, M. Jackson, and W. Thomas {beta}-Cell Function and the Development of Diabetes-Related Complications in the Diabetes Control and Complications Trial Diabetes Care, March 1, 2003; 26(3): 832 - 836. [Abstract] [Full Text] [PDF]

				M. J. Hamadeh and L. J. Hoffer Effect of protein restriction on sulfur amino acid catabolism in insulin-dependent diabetes mellitus Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E382 - E389. [Abstract] [Full Text] [PDF]

				S. D. Madsen, G. I. Roisman, and W. A. Collins The Intersection of Adolescent Development and Intensive Intervention: Age-Related Psychosocial Correlates of Treatment Regimens in the Diabetes Control and Complication Trial J. Pediatr. Psychol., July 1, 2002; 27(5): 451 - 459. [Abstract] [Full Text] [PDF]

				G. L. Booth, B. Zinman, and D. A. Redelmeier Diabetes Care in the U.S. and Canada Diabetes Care, July 1, 2002; 25(7): 1149 - 1153. [Abstract] [Full Text] [PDF]

				The Writing Team for the Diabetes Control and Comp Effect of Intensive Therapy on the Microvascular Complications of Type 1 Diabetes Mellitus JAMA, May 15, 2002; 287(19): 2563 - 2569. [Abstract] [Full Text] [PDF]

				R. R. Russell III, D. Chyun, S. Song, R. S. Sherwin, W. V. Tamborlane, F. A. Lee, M. A. Pfeifer, F. Rife, F. J. T. Wackers, and L. H. Young Cardiac responses to insulin-induced hypoglycemia in nondiabetic and intensively treated type 1 diabetic patients Am J Physiol Endocrinol Metab, November 1, 2001; 281(5): E1029 - E1036. [Abstract] [Full Text] [PDF]

				The Diabetes Control and Complications Trial Resea Influence of Intensive Diabetes Treatment on Body Weight and Composition of Adults With Type 1 Diabetes in the Diabetes Control and Complications Trial Diabetes Care, October 1, 2001; 24(10): 1711 - 1721. [Abstract] [Full Text] [PDF]

				M. J. Hamadeh, A. Schiffrin, and L. J. Hoffer Sulfate production depicts fed-state adaptation to protein restriction in humans Am J Physiol Endocrinol Metab, August 1, 2001; 281(2): E341 - E348. [Abstract] [Full Text] [PDF]

				M. J. Hamadeh and L. J. Hoffer Effect of protein restriction on 15N transfer from dietary [15N]alanine and [15N]Spirulina platensis into urea Am J Physiol Endocrinol Metab, August 1, 2001; 281(2): E349 - E356. [Abstract] [Full Text] [PDF]

				L. Zhang, G. Krzentowski, A. Albert, and P. J. Lefebvre Risk of Developing Retinopathy in Diabetes Control and Complications Trial Type 1 Diabetic Patients With Good or Poor Metabolic Control Diabetes Care, July 1, 2001; 24(7): 1275 - 1279. [Abstract] [Full Text] [PDF]

				V. Umpaichitra, W. Bastian, D. Taha, M. A. Banerji, T. W. AvRuskin, and S. Castells C-peptide and Glucagon Profiles in Minority Children with Type 2 Diabetes Mellitus J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1605 - 1609. [Abstract] [Full Text]

				R. G. Hiss, M. L. Gillard, B. A. Armbruster, and L. A. McClure Comprehensive Evaluation of Community-Based Diabetic Patients: Effect of feedback to patients and their physicians: a randomized controlled trial Diabetes Care, April 1, 2001; 24(4): 690 - 694. [Abstract] [Full Text]

				W. THOMAS, Y. SHEN, M. E. MOLITCH, and M. W. STEFFES Rise in Albuminuria and Blood Pressure in Patients Who Progressed to Diabetic Nephropathy in the Diabetes Control and Complications Trial J. Am. Soc. Nephrol., February 1, 2001; 12(2): 333 - 340. [Abstract] [Full Text]

				M. Gray, E. A. Boland, and W. V. Tamborlane Use of Lispro Insulin and Quality of Life in Adolescents on Intensive Therapy The Diabetes Educator, November 1, 1999; 25(6): 934 - 941. [Abstract] [PDF]

				F. L. Ferris, M. D. Davis, and L. M. Aiello Treatment of Diabetic Retinopathy N. Engl. J. Med., August 26, 1999; 341(9): 667 - 678. [Full Text] [PDF]

				T. M.S. Wolever, S. Hamad, J.-L. Chiasson, R. G. Josse, L. A. Leiter, N. W. Rodger, S. A. Ross, and E. A. Ryan Day-to-Day Consistency in Amount and Source of Carbohydrate Intake Associated with Improved Blood Glucose Control in Type 1 Diabetes J. Am. Coll. Nutr., June 1, 1999; 18(3): 242 - 247. [Abstract] [Full Text] [PDF]

				J. Q. Purnell, J. E. Hokanson, S. M. Marcovina, M. W. Steffes, P. A. Cleary, and J. D. Brunzell Effect of Excessive Weight Gain With Intensive Therapy of Type 1 Diabetes on Lipid Levels and Blood Pressure: Results From the DCCT JAMA, July 8, 1998; 280(2): 140 - 146. [Abstract] [Full Text] [PDF]

				The Diabetes Control and Complications Trial Resea Early Worsening of Diabetic Retinopathy in the Diabetes Control and Complications Trial Arch Ophthalmol, July 1, 1998; 116(7): 874 - 886. [Abstract] [Full Text] [PDF]

				Effect of Intensive Therapy on Residual {beta}-Cell Function in Patients with Type 1 Diabetes in the Diabetes Control and Complications Trial: A Randomized, Controlled Trial Ann Intern Med, April 1, 1998; 128(7): 517 - 523. [Abstract] [Full Text]

				L. J. Hoffer Adaptation to Protein Restriction Is Impaired in Insulin-Dependent Diabetes Mellitus J. Nutr., February 1, 1998; 128(2): 333 - 333. [Abstract] [Full Text]

				R. G. Hiss Barriers to Care in Non-Insulin-dependent Diabetes Mellitus: The Michigan Experience Ann Intern Med, January 1, 1996; 124(1_Part_2): 146 - 148. [Abstract] [Full Text]

				The Diabetes Control and Complications Trial Resea The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus N. Engl. J. Med., September 30, 1993; 329(14): 977 - 986. [Abstract] [Full Text]

				D. M. Nathan Long-Term Complications of Diabetes Mellitus N. Engl. J. Med., June 10, 1993; 328(23): 1676 - 1685. [Full Text]

				S. M. Strowig Initiation and Management of Insulin Pump Therapy The Diabetes Educator, January 1, 1993; 19(1): 50 - 58. [PDF]

				J. McKelvey, D. A. Waller, A. J. North, J. F. Marks, B. Schreiner, L. B. Travis, and Jayn. Murphy Reliability and Validity of the Diabetes Family Behavior Scale (DFBS) The Diabetes Educator, January 1, 1993; 19(2): 125 - 132. [PDF]

				J. Ahern, N. Grove, T. Strand, J. Wesche, C. Seibert, A. T. Brenneman, and W. V. Tamborlane The Impact of the Trial Coordinator in the Diabetes Control and Complications Trial (DCCT) The Diabetes Educator, January 1, 1993; 19(6): 509 - 512. [PDF]

				M. A. Powers A Review of Recent Events in the History of Diabetes Nutritional Care The Diabetes Educator, January 1, 1992; 18(5): 393 - 400. [PDF]

				J. S. Skyler Intensive Insulin Therapy: A Personal and Historical Perspective The Diabetes Educator, January 1, 1989; 15(1): 33 - 39. [PDF]

				J. Annahern, D. F. Kruger, P. M. Gatcomb, W. A. Petit, and W. V. Tamborlane The Diabetes Control and Complications Trial (DCCT): The Trial Coordinator Perspective: Report by the DCCT Research Group The Diabetes Educator, January 1, 1989; 15(3): 236 - 241. [PDF]

				V. L. Broadstone, D. A. Greene, J. Cyrus, and M. A. Pfeifer Diabetic Peripheral Neuropathy Part I: Sensorimotor Neuropathy The Diabetes Educator, January 1, 1987; 13(1): 30 - 35. [PDF]